Ozone Pharmaceuticals reported for 2024 by RAS

Ozone Pharmaceuticals' RAS net profit for 2024 amounted to ₽2.2 billion, up 2.1 times from ₽1.02 billion in the previous year. Revenue grew 2.8 times to ₽2.92 billion against ₽1.05 billion a year earlier.